{
  "patientId": "SB001",
  "demographics": {
    "name": "Arthur Pendelton",
    "dob": "1975-06-22",
    "gender": "Male",
    "address": "55 Castle Rd, Anytown, USA",
    "phone": "555-1212",
    "insurance": "Cigna - Policy #CIG-AP-197506",
    "referringPhysician": "Dr. Helen Merlin (Neuro-Oncology)",
    "emergencyContact": "Gwen Pendelton (Wife) - 555-1213",
    "advanceDirectives": "Full Code (On File, verified 01/25/2025)",
    "supportServices": "Nutritional support consult due to risk of mucositis and taste changes. Social work engaged for support during long treatment course. Referred to the Chordoma Foundation for patient resources.",
    "mobility": "Independent, Ambulatory. ECOG Performance Status 1 (symptomatic but fully ambulatory)."
  },
  "diagnosis": {
    "primary": "Chordoma, Conventional Type, WHO Grade 1",
    "location": "Clivus (Skull Base)",
    "datePathologicDiagnosis": "01/15/2025 (Biopsy via Endoscopic Endonasal Approach)",
    "tumorSize": "3.5 cm, involving the clivus and extending towards the sphenoid sinus, with significant mass effect on the brainstem.",
    "pathologicStage": "T2 N0 M0 (Skull Base Chordoma Staging)",
    "symptomsAtPresentation": "Patient presented with a 4-month history of persistent headaches and new onset of diplopia (double vision), particularly on lateral gaze.",
    "pathologyFindings": [
      "Endoscopic Biopsy (01/15/2025): Chordoma, Conventional Type. Sections show lobules of cells in a myxoid stroma. Characteristic physaliphorous cells with bubbly cytoplasm are present.",
      "Immunohistochemistry: Strong nuclear positivity for Brachyury, confirming diagnosis. Positive for Cytokeratin AE1/AE3 and S100."
    ],
    "priorTreatmentSummary": "Patient underwent an endoscopic, endonasal biopsy for diagnosis only. The tumor was deemed unresectable due to its proximity to and mass effect on the brainstem and critical neurovascular structures.",
    "relevantHistory": "No significant past medical history. Works as an architect. Non-smoker.",
    "baselineStatus": "ECOG 1. Neurologic exam notable for a right abducens nerve (CN VI) palsy causing diplopia. Otherwise, neurologically intact. Headaches are managed with OTC analgesics."
  },
  "treatmentPlan": {
    "radOnc": "Dr. Robert Evans",
    "neuroOnc": "Dr. Helen Merlin",
    "surgOnc": "Dr. Arthur Kingsley (Neurosurgery - for biopsy)",
    "treatmentSite": "Skull Base/Clivus",
    "intent": "Definitive (Curative)",
    "modality": "High-Dose Proton Beam Radiation Therapy",
    "totalDose": "74 Gy(RBE)",
    "fractionation": "37 fx",
    "rtRxDetails": "74 Gy(RBE) in 37 fractions (2.0 Gy(RBE)/fx)",
    "targetVolumeSummary": "The GTV includes all visible tumor on the fused MRI/CT scan. The CTV is a 5mm expansion on the GTV, and the PTV is an additional 3mm expansion. The plan is designed to deliver a high dose to the tumor while maximally sparing the adjacent brainstem, optic chiasm, optic nerves, and temporal lobes.",
    "techniqueSummary": "Intensity-Modulated Proton Therapy (IMPT) using pencil beam scanning. This technique is chosen over standard photon radiation to leverage the Bragg peak effect of protons, which allows for a sharp dose fall-off and superior sparing of critical nearby neurologic structures.",
    "concurrentChemo": "None",
    "medications": [
      "Dexamethasone 4mg PO BID, to start 3 days prior to RT and continue through first week, then taper as tolerated.",
      "Ondansetron (Zofran) 8mg PO PRN for nausea.",
      "Artificial tears PRN for dry eyes.",
      "Saline nasal spray PRN for nasal dryness/congestion."
    ],
    "therapistAlerts": [
      "This is a high-precision proton therapy plan. Daily IGRT with orthogonal x-rays and verification of bony anatomy is critical.",
      "Patient is immobilized in a tight-fitting mask with a bite block. Monitor for anxiety or claustrophobia.",
      "Assess for any new or worsening neurologic symptoms daily (vision changes, headache, weakness, dizziness). Report immediately to RN/MD.",
      "Monitor for acute side effects such as mucositis, taste changes, and fatigue, which may become significant during the long course of treatment.",
      "Confirm all beam-modifying devices (aperture, compensator) are correct for each field."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "02/10/2025",
      "setupInstructions": "Supine in a custom thermoplastic mask with a personalized bite block to ensure reproducibility of jaw position. Head is in a neutral position, immobilized to the couch.",
      "immobilization": "Custom thermoplastic mask (Head), integrated bite block, custom headrest.",
      "referenceMarks": "Marks placed on the mask are aligned to room lasers. Isocenter coordinates managed by the TPS.",
      "scanner": "Siemens Somatom Definition AS",
      "sliceThickness": "1.0 mm",
      "contrastUsed": "IV Contrast was administered for the CT scan to aid in fusion with the diagnostic MRI.",
      "ctNotes": "High-resolution CT of the head acquired in the treatment mask. The scan was successfully fused with the diagnostic MRI of the Brain/Skull Base for precise proton planning. The patient tolerated the procedure well and the setup appears highly reproducible."
    },
    "dosimetry": {
      "planId": "APSB001_Chordoma_IMPT",
      "planStatus": "Final - Approved by Dr. Robert Evans (02/15/2025)",
      "rx": "74 Gy(RBE) / 37 fx",
      "technique": "IMPT (Pencil Beam Scanning)",
      "energy": "Protons (variable range/energy)",
      "tps": "RayStation Proton v12",
      "algorithm": "Monte Carlo",
      "hetero": "Yes",
      "norm": "98% of PTV receives 74 Gy(RBE)",
      "constraints": "Brainstem Max < 54 Gy(RBE) (achieved 53.8 Gy(RBE)); Optic Chiasm Max < 54 Gy(RBE) (achieved 52.1 Gy(RBE)); Left Optic Nerve Max < 54 Gy(RBE) (achieved 51.5 Gy(RBE)); Right Temporal Lobe V45Gy < 10cc (achieved 8.5cc).",
      "planNotes": "High-dose definitive proton therapy for clival chordoma. Pencil beam scanning is utilized to 'paint' the dose, achieving a highly conformal distribution with a sharp dose fall-off that spares the critical, surrounding neurological structures. Daily IGRT is essential.",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "Orthogonal kV X-rays",
        "alignment": "Primary match to bony anatomy of the skull base.",
        "tolerances": "Translational: +/- 1mm; Rotational: +/- 0.5 degrees."
      },
      "qaChecks": [
        { "date": "2025-02-15", "type": "Initial Chart Check", "by": "Physics Staff (AK)", "result": "Pass" },
        { "date": "2025-02-15", "type": "Patient Specific QA (IMPT)", "by": "Medical Physicist (SD)", "result": "Pass (3D Gamma analysis > 99%)" }
      ],
      "fieldDetails": [
        { "fieldName": "Left Posterior Oblique", "fieldSize": "Aperture defined", "gantryAngle": "220", "energy": "Variable", "ssd": "N/A (Proton)" },
        { "fieldName": "Right Posterior Oblique", "fieldSize": "Aperture defined", "gantryAngle": "140", "energy": "Variable", "ssd": "N/A (Proton)" },
        { "fieldName": "Vertex", "fieldSize": "Aperture defined", "gantryAngle": "0", "energy": "Variable", "ssd": "N/A (Proton)" }
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        {
          "fractionNumber": 1, "totalFractions": 37, "date": "2025-02-17", "machine": "Proton Gantry 2", "therapistInitials": "JL, MW",
          "recordedFields": [{ "fieldName": "All Fields", "deliveredMu": "N/A (spots)", "notes": "Fields delivered per plan." }],
          "energiesUsed": "Protons", "setupVerification": "Tolerances Met", "immobilizationDevicesChecked": "Thermoplastic mask, bite block", "setupAdjustments": "None", "organTargetChecks": "Daily orthogonal x-rays reviewed. Match to skull base excellent.", "imagingType": "kV X-ray", "igrtMatchQuality": "Excellent", "igrtApprovedBy": "RE (Physician)",
          "patientTolerance": "Good", "generalSideEffects": "None", "siteSpecificSideEffects": "None", "painAssessment": "3/10 (headache)", "patientConcerns": "Anxious about the long course of treatment.", "instructionsGiven": "Reassured patient. Reviewed schedule and supportive care medications.", "billingCodes": "77525, 77387", "dailyNotes": "First treatment delivered without issue. Patient tolerated the mask and bite block well."
        },
        {
          "fractionNumber": 15, "totalFractions": 37, "date": "2025-03-10", "machine": "Proton Gantry 2", "therapistInitials": "JL, MW",
          "recordedFields": [{ "fieldName": "All Fields", "deliveredMu": "N/A (spots)", "notes": "All fields delivered per plan." }],
          "energiesUsed": "Protons", "setupVerification": "Tolerances Met", "immobilizationDevicesChecked": "Thermoplastic mask, bite block", "setupAdjustments": "None", "organTargetChecks": "Daily IGRT match remains stable.", "imagingType": "kV X-ray", "igrtMatchQuality": "Good", "igrtApprovedBy": "Therapist",
          "patientTolerance": "Good", "generalSideEffects": "Mild fatigue.", "siteSpecificSideEffects": "Mild mucositis in nasopharynx. Some taste alteration.", "painAssessment": "1/10 (headache)", "patientConcerns": "Food tastes 'like metal'.", "instructionsGiven": "Nutritional consult recommendations reviewed. Encourage hydration and use of saline nasal spray.", "billingCodes": "77525, 77387, 77427", "dailyNotes": "OTV today. Patient managing side effects well. Neurologic exam stable, diplopia unchanged."
        },
        {
          "fractionNumber": 30, "totalFractions": 37, "date": "2025-04-02", "machine": "Proton Gantry 2", "therapistInitials": "JL, MW",
          "recordedFields": [{ "fieldName": "All Fields", "deliveredMu": "N/A (spots)", "notes": "All fields delivered per plan." }],
          "energiesUsed": "Protons", "setupVerification": "Tolerances Met", "immobilizationDevicesChecked": "Thermoplastic mask, bite block", "setupAdjustments": "None", "organTargetChecks": "Daily IGRT match remains stable.", "imagingType": "kV X-ray", "igrtMatchQuality": "Good", "igrtApprovedBy": "Therapist",
          "patientTolerance": "Fair", "generalSideEffects": "Moderate fatigue.", "siteSpecificSideEffects": "Grade 2 mucositis. Taste changes more significant. Dry mouth.", "painAssessment": "2/10 (mouth sores)", "patientConcerns": "Difficulty eating solid foods.", "instructionsGiven": "Reinforced use of nutritional supplements. Magic mouthwash prescribed.", "billingCodes": "77525, 77387, 77427", "dailyNotes": "OTV today. Patient is losing some weight due to mucositis. Nutrition team actively involved. Patient remains motivated."
        },
        {
          "fractionNumber": 37, "totalFractions": 37, "date": "2025-04-11", "machine": "Proton Gantry 2", "therapistInitials": "JL, MW",
          "recordedFields": [{ "fieldName": "All Fields", "deliveredMu": "N/A (spots)", "notes": "All fields delivered per plan." }],
          "energiesUsed": "Protons", "setupVerification": "Tolerances Met", "immobilizationDevicesChecked": "Thermoplastic mask, bite block", "setupAdjustments": "None", "organTargetChecks": "Final IGRT reviewed.", "imagingType": "kV X-ray", "igrtMatchQuality": "Excellent", "igrtApprovedBy": "RE (Physician)",
          "patientTolerance": "Fair", "generalSideEffects": "Significant fatigue.", "siteSpecificSideEffects": "Mucositis improving slightly. Persistent taste changes.", "painAssessment": "1/10", "patientConcerns": "Very relieved to complete treatment. Worried about late side effects.",
          "instructionsGiven": "End-of-treatment instructions provided. Side effects will resolve over several weeks to months. Explained importance of long-term MRI follow-up and endocrine monitoring.", "billingCodes": "77525, 77387, 77427", "dailyNotes": "Final proton therapy fraction delivered. Patient and wife are relieved. Full course completed without interruption. Excellent compliance."
        }
      ]
    }
  },
  "progressNotes": [
    { "date": "01/10/2025", "author": "Dr. Helen Merlin (Neuro-Onc)", "type": "Consult Note", "summary": "49yo M presents with persistent headaches and new diplopia. MRI reveals a large clival mass characteristic of a chordoma. Given the intimate involvement with the brainstem, this is surgically unresectable. Plan is for endoscopic biopsy for tissue confirmation, followed by referral to Radiation Oncology for definitive high-dose radiation. Proton therapy will be strongly recommended." },
    { "date": "01/25/2025", "author": "Dr. Robert Evans (Rad Onc)", "type": "Initial Consult", "summary": "Patient with biopsy-proven unresectable clival chordoma. Reviewed all imaging and pathology. Discussed definitive high-dose radiation therapy. I have strongly recommended proton therapy (IMPT) over photons due to the critical location, which will allow for superior sparing of the brainstem, temporal lobes, and optic structures. We will plan for a total dose of 74 Gy(RBE) in 37 fractions. Discussed the long treatment course and the potential for acute side effects (fatigue, mucositis, taste changes) and late effects (risk to vision, hearing, pituitary function, and brain tissue). Patient and his wife understand the rationale and wish to proceed. CT simulation for proton planning scheduled." },
    { "date": "03/10/2025", "author": "Dr. Robert Evans (Rad Onc)", "type": "OTV - Week 4", "summary": "Patient has completed 15/37 fractions. He is tolerating treatment well. Reports mild fatigue and early taste alterations. Neurologic exam is stable with no worsening of his diplopia. He denies significant headaches. Setup is highly reproducible. Plan to continue." },
    { "date": "04/11/2025", "author": "Dr. Robert Evans (Rad Onc)", "type": "End of Treatment Note", "summary": "Arthur has successfully completed his course of high-dose proton therapy to 74 Gy(RBE). He developed expected Grade 2 mucositis and moderate fatigue, which are improving. His neurologic status remains stable. He will have his first follow-up MRI in 3 months. Long-term endocrine and ophthalmology follow-up will be critical. Prognosis for local control is good given the high dose delivered with protons." }
  ]
}
